Zydus Announces Settlement of a DELZICOL

Zydus Announces Settlement of a DELZICOL® (mesalamine) Patent Litigation Ahmedabad, Dec. 3, 2016 Zydus Cadila, an innovation -driven global pharmaceutical company, announced that the patent litigation relating to Allergan's DELZICOL® (mesalamine) has been settled. As a result of the settlement, and if approved by FDA, its US subsidiary, Zydus Pharmaceuticals (USA) Inc., will be able to market its generic version of DELZICOL® in the United States beginning on March 1, 2020, or earlier under certain circumstances. ###

The release as fetched from its publisher. zyduslife.com ↗